ImpediMed Limited

ImpediMed Limited is a medical device company headquartered in Carlsbad, California. The company employs 102 people and generates $7 million in annual revenue. ImpediMed focuses on developing and distributing medical devices utilizing bioimpedance spectroscopy (BIS) technology. Their primary products are designed to assist surgeons, oncologists, therapists, and radiation oncologists in evaluating patients for the risk of developing secondary lymphoedema, a condition that can arise after cancer treatment. ImpediMed's technology allows healthcare professionals to conduct noninvasive assessments that can help identify potential issues before symptoms manifest. Early detection through these assessments aims to prevent lymphoedema from becoming a chronic problem, ultimately enhancing the quality of life for cancer survivors. The company holds the distinction of having the first FDA-cleared medical device in the United States specifically designed to aid healthcare professionals in assessing secondary lymphoedema in the arms and legs of both male and female cancer patients. For more information, please visit their website at impedimed.com.